2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.32+$0.04 (+1.25%)
Price as of Aug 21, 2026 7:32 PM EDT- $714.7MMarket Cap
- 54.72%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.32+$0.04 (+1.25%)
Earnings Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 21 |
Momentum Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -8.52% | ||
12-Month Momentum | 64.04% | ||
3-Month Risk Adjusted Momentum | -38.41% | ||
12-Month Risk Adjusted Momentum | 72.57% |
True Yield
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 3.80% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CTMX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |